Postmethoxyflurane hepatitis: a clinical entity.
D000328:Adult; D000769:Anesthesia, Inhalation / Q000009:adverse effects*; D000773:Anesthesia, Obstetrical / Q000009:adverse effects*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001663:Bilirubin / Q000097:blood; D056486:Chemical and Drug Induced Liver Injury / Q000097:blood / Q000188:drug therapy / Q000209:etiology*; D002763:Cholecystectomy; D004804:Eosinophils / Q000032:analysis; D005260:Female; D006221:Halothane / Q000009:adverse effects; D006801:Humans; D007565:Jaundice / Q000139:chemically induced; D007958:Leukocyte Count; D008297:Male; D008733:Methoxyflurane / Q000009:adverse effects*; D011183:Postoperative Complications; D011247:Pregnancy; D013256:Steroids / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D013256:Steroids; D008733:Methoxyflurane; D001663:Bilirubin; D006221:Halothane